BCAB - BioAtla, Inc.
0.448
-0.027 -6.094%
Share volume: 355,993
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.48
-0.03
-0.06%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 08-01-2023 | 11-07-2023 | 11-07-2024 | 05-14-2024 | 08-08-2024 | 11-07-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 11.000 M | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 11.000 M | 0.000 | |
| nan% | nan% | nan% | nan% | inf% | -100.00% | ||||
| Operating expenses | 28.930 M | 37.201 M | 35.020 M | 28.536 M | 24.457 M | 21.972 M | 22.270 M | 16.244 M | |
| Selling general and admin | 7.233 M | 6.241 M | 6.620 M | 5.862 M | 5.605 M | 5.774 M | 5.875 M | 4.594 M | |
| Research and development | 21.697 M | 30.960 M | 28.400 M | 22.674 M | 18.852 M | 16.198 M | 16.395 M | 11.650 M | |
| Total expenses | 28.930 M | 37.201 M | 35.020 M | 28.536 M | 24.457 M | 21.972 M | 22.270 M | 16.244 M | |
| 28.59% | -5.86% | -18.52% | -14.29% | -10.16% | 1.36% | -27.06% | |||
| Operating income | -28.930 M | -37.201 M | -35.020 M | -28.536 M | -24.457 M | -21.972 M | -11.270 M | -16.244 M | |
| Ebit | -28.940 M | -37.212 M | -35.059 M | -28.563 M | -24.457 M | -21.972 M | -11.278 M | -15.438 M | |
| Pretax income | -27.460 M | -35.752 M | -33.325 M | -26.925 M | -23.234 M | -21.072 M | -10.586 M | -14.884 M | |
| 30.20% | -6.79% | -19.20% | -13.71% | -9.31% | -49.76% | 40.60% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -27.460 M | -35.752 M | -33.325 M | -26.925 M | -23.234 M | -21.072 M | -10.586 M | -14.884 M | |
| -30.20% | 6.79% | 19.20% | 13.71% | 9.31% | 49.76% | -40.60% |
